Adding adjuvant chemotherapy to radiotherapy did not lead to a significant survival benefit over radiotherapy alone in women ...

The addition of concurrent cisplatin to adjuvant radiation therapy conferred no benefit to women with intermediate-risk, ...

Current guidelines lack consensus and rely on lower-quality evidence, according to the author of new research.

The addition of pembrolizumab to chemoradiotherapy improved survival outcomes for women with high-risk, locally advanced ...

In the CRT arm, a dose of cisplatin 40 mg/m 2 was administered ... first U.S.-based clinical trial on early-stage high-risk cervical cancer that collected PRO/QoL data prospectively.

Results from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy ... intermediate-risk cervical carcinoma indicated that the addition of ...

The National Health Fund (NHF) has announced that effective March 27, 2025, attention deficit hyperactivity disorder (ADHD) and cervical cancer are covered on the NHF's Card Programme, bringing the ...

Results from the NRG Oncology GOG-0263 Phase III clinical trial testing the addition of cisplatin-based chemotherapy ... intermediate-risk cervical carcinoma indicated that the addition of ...

Cervical Cancer: Subsidies are now available for eight APIs used in treatment, including Bevacizumab, Carboplatin, Cisplatin, Gemcitabine, Filgrastim, Paclitaxel injections, as well as ...

Statistics show this women's cancer previously took an average of 4,300 lives per year. Here's how new research is making an ...